These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 620405)

  • 1. Effect of lysolecithin and analogs on mouse ascites tumors.
    Tarnowski GS; Mountain IM; Stock CC; Munder PG; Weltzien HU; Westphal O
    Cancer Res; 1978 Feb; 38(2):339-44. PubMed ID: 620405
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of antitumor activity of bleomycin towards solid tumors in mice by Bacillus thuringiensis subsp. israelensis toxin.
    Yokoyama Y; Ohmori I; Kohda K; Kawazoe Y
    Anticancer Res; 1991; 11(4):1625-8. PubMed ID: 1720939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An evaluation of the toxic and antitumor action of farmorubicin administered to H-strain mice with Ehrlich ascitic cancer].
    Karaivanova MKh; Prokopanov Kh; Getov Kh
    Eksp Onkol; 1990; 12(2):71-3, 81. PubMed ID: 2318138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice].
    Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE
    Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of mouse ascites tumors by the treatment with bacterial extracts.
    Watanabe T
    Jpn J Exp Med; 1966 Aug; 36(4):453-5. PubMed ID: 5338893
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acceleration of growth of transplantable tumors and change in the sensitivity to chemotherapy on administration of creatinine].
    Pukhal'skaia ECh; Platonova GN
    Biull Eksp Biol Med; 1971 Oct; 72(10):82-5. PubMed ID: 5126158
    [No Abstract]   [Full Text] [Related]  

  • 7. [Some characteristics of the biological action of D, L-1,4-dibromo-1,4-dideoxy-2,3-butanediol].
    Miuller NR; Remizov AL; Belogorodskiĭ VV; Filov VA
    Farmakol Toksikol; 1975; 38(5):590-1. PubMed ID: 1191387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of differential cytotoxic compounds containing nitrosourea and benzothiazine nucleus.
    Nyati MK; Rai D; Gupta RR; Dev PK
    In Vivo; 1997; 11(1):95-9. PubMed ID: 9067778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mitosis rate in Jensen sarcoma, in a DANA lung carcinoma and in Ehrlich ascites tumor in iron deficiency and iron overloading].
    Kranz D; Schmidt UJ; Kalbe I; Brüschke G; Pasternak G
    Acta Biol Med Ger; 1969; 22(3):653-6. PubMed ID: 4903492
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of non-specific resistance and specific immune response against tumours in mice by synthetic muramyl dipeptide.
    Nĕmecková S; Bubeník J; Jezek J; Zaoral M
    Folia Biol (Praha); 1982; 28(5):327-33. PubMed ID: 7173449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of transplantable tumors in mice by monomethylformamide].
    Smoryzanova OA; Proskuriakov SIa; Dedenkov AN; Riabchenko NI
    Vopr Onkol; 1989; 35(8):967-70. PubMed ID: 2800445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phytohemagglutinin on ascites tumor and SV40 induced sarcoma of hamsters.
    Robinson E; Ashkenazi A
    Isr J Med Sci; 1967; 3(6):822-6. PubMed ID: 4297381
    [No Abstract]   [Full Text] [Related]  

  • 13. [The principle of tumor chemotherapy, studied by the transformation of tumor cells into anaerobic cells, resistant to active oxygen].
    Petrovskiĭ BV; Kogan AKh; Efuni SN; Chernov VA; Sinianskaia VA
    Dokl Akad Nauk SSSR; 1981; 256(5):1273-7. PubMed ID: 6262035
    [No Abstract]   [Full Text] [Related]  

  • 14. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
    Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
    Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukemoid reaction in BALB-c mice bearing transplanted tumors.
    Kodama T; Sendo F; Kobayashi H
    Cancer Res; 1974 Jan; 34(1):176-80. PubMed ID: 4809456
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced toxicity and enhanced antitumor efficacy of betacyclodextrin plumbagin inclusion complex in mice bearing Ehrlich ascites carcinoma.
    Singh UV; Udupa N
    Indian J Physiol Pharmacol; 1997 Apr; 41(2):171-5. PubMed ID: 9142565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival time of mice bearing Ehrlich ascites tumor, with special reference to the effect of hydrocortisone administration.
    Kodama M; Amo H; Kodama T
    J Natl Cancer Inst; 1970 May; 44(5):1055-64. PubMed ID: 5514471
    [No Abstract]   [Full Text] [Related]  

  • 18. Antitumor effect of polysaccharide TC-13 on allogeneic and syngeneic tumors in mice.
    Kohno M; Abe S; Yamazaki M; Mizuno D
    Gan; 1982 Jun; 73(3):488-94. PubMed ID: 7129013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some observations on the action of actinomycin D, mitomycin C and jawaharene on transplanted mouse fibrosarcoma.
    Roy A; Chatterjee PC
    Indian J Cancer; 1974 Dec; 11(4):394-8. PubMed ID: 4468244
    [No Abstract]   [Full Text] [Related]  

  • 20. A new substance effective against transplantable tumors in vivo: L-cystine-bis-(N,N-beta-chloroethyl)-hydrazide.
    Golovinsky EV; Alexiev BV; Spassov AV; Stoev SB; Emanuilov EA; Angelov II; Maneva LS; Stoychev TS
    Neoplasma; 1977; 24(4):401-4. PubMed ID: 904741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.